Please assess the completion status of the following clinical trial:

Trial Title: Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 or older~* Patient indicated for biliary metal stent placement for the treatment of jaundice and/or cholestasis~* Willing and able to comply with the study procedures and provide written informed consent to participate in the study~* Suspicion of pancreatic adenocarcinoma~* Likely indicated for neoadjuvant treatment~* Distal biliary obstruction consistent with pancreatic cancer~* Location of distal biliary obstruction such that it would allow the proximal end of a stent to be positioned at least 2 cm from the hilum~* Endoscopic and surgical treatment to be provided at the same institution~Exclusion Criteria:~* Benign biliary strictures~* Malignancy secondary to Intraductal Papillary Mucinous Neoplasm~* Surgically altered anatomy where ERCP is not possible~* Previous biliary drainage using a SEMS or multiple plastic stents~* Contraindications for endoscopic techniques~* Patients who are currently enrolled in another investigational trial that would directly interfere with the current study~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- WallFlex Biliary RX Fully Covered Stent System (Type: ACTIVE_COMPARATOR): Patients in this group will receive a fully covered study SEMS (self-expanding metal stent)~Reintervention can occur with either a WallFlex™ Biliary RX Fully Covered or Uncovered Stent System
- WallFlex Biliary RX Uncovered Stent System (Type: ACTIVE_COMPARATOR): Patients in this group will receive an uncovered study SEMS (self-expanding metal stent).~Reintervention can occur with either a WallFlex™ Biliary RX Fully Covered or Uncovered Stent System

Based on this trial design, predict the completion outcome and termination type (if applicable).